Viracta Therapeutics (VIRX) Q2 2025 Earnings

7MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-0.37
-0.31
-0.26
-0.21

Details

Expected EPS
-0.21
Actual EPS
N/A
Surprise EPS
0.21
Surprise Percent
+100%

Description

Viracta Therapeutics (VIRX) will report earnings of for Q2 2025 on May 07, 2025.

0 Comments

Share your thoughts